Patents by Inventor Mustafa MOROGLU

Mustafa MOROGLU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 12630516
    Abstract: The invention relates to compounds of formula (I): and related aspects.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: May 19, 2026
    Assignee: NRG THERAPEUTICS LTD.
    Inventors: Neil Miller, Richard Rutter, Jan Kulagowski, Richard Morphy, Tammy Ladduwahetty, John Maclean, Mustafa Moroglu, Eric Talbot, Michael Rowley
  • COMPOUNDS AS PARP1 INHIBITIORS
    Publication number: 20250289814
    Abstract: Disclosed herein is the compounds and pharmaceutically acceptable salts thereof that inhibit the Poly (ADP-ribose) polymerase (PARP) family of enzymes. The present disclosure also relates to the use of these compounds or pharmaceutically acceptable salts thereof in the treatment of diseases.
    Type: Application
    Filed: February 20, 2023
    Publication date: September 18, 2025
    Inventors: Tingzhong WANG, Zhenhai SHEN, Eric P A TALBOT, Joseph M. BATEMAN, Benjamin F. RAHEMTULLA, Mustafa MOROGLU, Tammy LADDUWAHETTY
  • ACRYLAMIDE COMPOUNDS
    Publication number: 20250179028
    Abstract: The invention relates to compounds of formula (I): (I) and related aspects.
    Type: Application
    Filed: March 2, 2023
    Publication date: June 5, 2025
    Applicant: NRG THERAPEUTICS LTD
    Inventors: Neil MILLER, Richard RUTTER, Jan KULAGOWSKI, Richard MORPHY, Tammy LADDUWAHETTY, John MACLEAN, Mustafa MOROGLU, Eric TALBOT, Michael ROWLEY, Christopher G. THOMSON
  • Process for Preparing a Macrocyclic Compound Having ENT1 Inhibiting Activity
    Publication number: 20240400581
    Abstract: The present disclose includes, among other things, methods of preparing compound (R)-11. or a pharmaceutically acceptable salt thereof. Compound (R)-11 is useful to treat or lessen the severity of cancer.
    Type: Application
    Filed: April 2, 2024
    Publication date: December 5, 2024
    Applicant: iTeos Belgium SA
    Inventors: Michael Deligny, Eric Talbot, Mustafa Moroglu, Didier Roche, Hugues Lemoine, Xin Huang, Cuicui Yuan, Deju Shang
  • Macrocyclic Compounds Having ENT1 Inhibiting Activity
    Publication number: 20240368183
    Abstract: The present disclose includes, among other things, compounds of formula (I) that treat or lessen the severity of cancer, pharmaceutical compositions and methods of making and using the same.
    Type: Application
    Filed: March 26, 2024
    Publication date: November 7, 2024
    Applicant: iTeos Belgium SA
    Inventors: Michael Deligny, Erica Joke Katelijne Heleen Houthuys, Eric Talbot, Mustafa Moroglu
  • NOVEL COMPOUNDS
    Publication number: 20240067614
    Abstract: The invention relates to compounds of formula (I): and related aspects.
    Type: Application
    Filed: September 1, 2021
    Publication date: February 29, 2024
    Applicant: NRG Therapeutics Ltd.
    Inventors: Neil MILLER, Richard RUTTER, Jan KULAGOWSKI, Richard MORPHY, Tammy LADDUWAHETTY, John MACLEAN, Mustafa MOROGLU, Eric TALBOT, Michael ROWLEY